𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Intensity of vascular endothelial growth factor expression is associated with increased risk of recurrence and decreased disease-free survival in papillary thyroid cancer

✍ Scribed by Colleen M. Lennard; Aneeta Patel; John Wilson; Brian Reinhardt; Caroline Tuman; Cydney Fenton; Elizabeth Blair; Gary L. Francis; R.Michael Tuttle

Book ID
117849461
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
162 KB
Volume
129
Category
Article
ISSN
0039-6060

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A common 936 C/T gene polymorphism of va
A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk
✍ Peter Krippl; Uwe Langsenlehner; Wilfried Renner; Babak Yazdani-Biuki; Gerald Wo πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 81 KB πŸ‘ 1 views

## Abstract A common 936 C/T polymorphism in the gene for the vascular endothelial growth factor (VEGF) has been associated with VEGF plasma levels. In our case‐control study, we investigated the role of this polymorphism for breast cancer risk. VEGF genotype was determined in 500 women with breast

Elevated expression of vascular endothel
Elevated expression of vascular endothelial growth factor correlates with increased angiogenesis and decreased progression-free survival among patients with low-grade neuroendocrine tumors
✍ Jun Zhang; Zhiliang Jia; Qiang Li; Liwei Wang; Asif Rashid; Zhenggang Zhu; Dougl πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 614 KB

## Abstract ## BACKGROUND Vascular endothelial growth factor (VEGF) is a critical proangiogenic factor in solid tumors. However, its expression and role in human neuroendocrine tumor development and progression remains unclear. ## METHODS Using immunohistochemistry, VEGF and Sp1 expression patte